- Home
- BTMD
BTMD
Biote Corp.
as 12-20-2024 3:32pm EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 198.2M | IPO Year: | N/A |
| Target Price: | $9.11 | AVG Volume (30 days): | 152.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.65 - $8.44 | Next Earning Date: | 11-12-2024 |
| Revenue: | $193,060,000 | Revenue Growth: | 4.84% |
| Revenue Growth (this year): | 9.27% | Revenue Growth (next year): | 14.82% |
Latest Biote Corp. News
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?
Zacks
6 days ago
Should Value Investors Buy biote Corp. (BTMD) Stock?
Zacks
18 days ago
Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect?
Zacks
23 days ago
Are Investors Undervaluing biote Corp. (BTMD) Right Now?
Zacks
a month ago
biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
GuruFocus.com
a month ago
Biote Corp (BTMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Enhancements
Zacks
a month ago
Wall Street Analysts Predict a 76.99% Upside in biote Corp. (BTMD): Here's What You Should Know
Zacks
a month ago
Is biote Corp. (BTMD) Stock Undervalued Right Now?
Compare BTMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.